- Home
- ARBE vs ENTX Comparison
ARBE vs ENTX Comparison
Compare ARBE & ENTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARBE
- ENTX
- Stock Information
- Founded
- ARBE 2015
- ENTX 2010
- Country
- ARBE Israel
- ENTX Israel
- Employees
- ARBE N/A
- ENTX N/A
- Industry
- ARBE EDP Services
- ENTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARBE Technology
- ENTX Health Care
- Exchange
- ARBE Nasdaq
- ENTX Nasdaq
- Market Cap
- ARBE 124.2M
- ENTX 101.3M
- IPO Year
- ARBE N/A
- ENTX 2018
- Fundamental
- Price
- ARBE $1.47
- ENTX $2.11
- Analyst Decision
- ARBE Buy
- ENTX Strong Buy
- Analyst Count
- ARBE 2
- ENTX 1
- Target Price
- ARBE $1.75
- ENTX $10.00
- AVG Volume (30 Days)
- ARBE 1.2M
- ENTX 43.2K
- Earning Date
- ARBE 05-20-2025
- ENTX 05-09-2025
- Dividend Yield
- ARBE N/A
- ENTX N/A
- EPS Growth
- ARBE N/A
- ENTX N/A
- EPS
- ARBE N/A
- ENTX N/A
- Revenue
- ARBE $768,000.00
- ENTX $223,000.00
- Revenue This Year
- ARBE $398.05
- ENTX N/A
- Revenue Next Year
- ARBE $366.67
- ENTX N/A
- P/E Ratio
- ARBE N/A
- ENTX N/A
- Revenue Growth
- ARBE N/A
- ENTX N/A
- 52 Week Low
- ARBE $0.85
- ENTX $1.41
- 52 Week High
- ARBE $5.09
- ENTX $2.79
- Technical
- Relative Strength Index (RSI)
- ARBE 61.54
- ENTX 52.23
- Support Level
- ARBE $1.30
- ENTX $2.08
- Resistance Level
- ARBE $1.43
- ENTX $2.41
- Average True Range (ATR)
- ARBE 0.09
- ENTX 0.19
- MACD
- ARBE 0.03
- ENTX -0.00
- Stochastic Oscillator
- ARBE 91.67
- ENTX 38.16
About ARBE Arbe Robotics Ltd.
Arbe Robotics Ltd is a provider of 4D Imaging Radar solutions enabling driver-assist systems while paving the way for fully autonomous driving. It is a research and development company in the field of chips for Advanced radar systems, which are mainly intended to be used as Advanced Driver Assistance Systems (ADAS) adapted for autonomous vehicles as well as for non-automotive uses. Its geographical segments include Sweden, China, Germany, USA, and others.
About ENTX Entera Bio Ltd.
Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins. The company focuses on underserved, chronic medical conditions where oral administration of a mini tablet peptide or peptide replacement therapy has the potential to significantly shift a treatment paradigm. Its product candidates are; EB613 for the treatment of osteoporosis and EB612 for the treatment of hypoparathyroidism are first-in-class mini tablet formulations of synthetic human PTH (1-34) (teriparatide), designed to have differing pharmacokinetic, or PK, profiles.